The role of NNRTIs in antiretroviral combination therapy: an introduction

In October 2000 a meeting was convened by DuPont Pharma in Scotland to disc uss the role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in antiretroviral therapy. The Round Table meeting focused on comparisons bet ween efavirenz and nevirapine in clinical studies and clinical practice, an d the manuscripts published in this supplement report the most salient poin ts from the presentations and discussions.